This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The SP 500 index level can hint at breadth and momentum, helping you gauge whether moves are broad-based or narrow.
23,589 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A high-profile insider move raises questions about strategy and sentiment. This article breaks down the Paychex share...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
MP Materials is shaping the materials landscape with its Mountain Pass operation. This guide breaks down what to wat...
Today’s stock market today faces mixed signals as The Trade Desk slides on a Q1 miss and softer guidance. Here’s what...
Chinese automakers are shifting from passenger cars to commercial fleets, challenging Ford's margins and strategy. Th...
Investor sentiment shifted on a day when Poet Technologies announced a large equity offering. This piece explains wha...
A new crackdown targets the cartel’s use of digital money to move profits. Learn how treasury sanctions sinaloa carte...
A comprehensive, reader-friendly analysis of CVV's Q4 2025 earnings transcript. Learn how revenue trends, margins, an...
Accenture stands out as a strong contender in the consulting arena. This article digs into why investors should pay a...
What happens when a retail giant leans on crypto to boost cash ahead of earnings? This analysis dives into a hypothet...
This in-depth piece dives into Chile's bold tax reform plan and what it could mean for growth, investment, and global...